117 related articles for article (PubMed ID: 17227734)
1. Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure.
Feola M; Rosso GL; Peano M; Agostini M; Aspromonte N; Carena G; Salvatico L; Valle R
Arch Med Res; 2007 Feb; 38(2):234-9. PubMed ID: 17227734
[TBL] [Abstract][Full Text] [Related]
2. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
[TBL] [Abstract][Full Text] [Related]
3. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
Hogenhuis J; Jaarsma T; Voors AA; Hillege HL; Lesman I; van Veldhuisen DJ
Int J Cardiol; 2006 Mar; 108(1):63-7. PubMed ID: 16516699
[TBL] [Abstract][Full Text] [Related]
4. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
[TBL] [Abstract][Full Text] [Related]
5. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure.
Feola M; Menardi E; Ribichini F; Vado A; Deorsola A; Ferrero V; Visconti G; Milanese U; Uslenghi E
Med Sci Monit; 2003 Aug; 9(8):CR341-5. PubMed ID: 12942029
[TBL] [Abstract][Full Text] [Related]
6. The implantable cardioverter defibrillator in congestive heart failure patients in primary prevention: assessment of neuropsychological impact.
Garnero S; Pomero A; Vallauri P; Leto L; Testa M; Feola M
Minerva Cardioangiol; 2014 Aug; 62(4):321-6. PubMed ID: 24825101
[TBL] [Abstract][Full Text] [Related]
7. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
8. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairment: a key feature of congestive heart failure in the elderly.
Trojano L; Antonelli Incalzi R; Acanfora D; Picone C; Mecocci P; Rengo F;
J Neurol; 2003 Dec; 250(12):1456-63. PubMed ID: 14673579
[TBL] [Abstract][Full Text] [Related]
11. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
12. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
[TBL] [Abstract][Full Text] [Related]
13. Contributors to cognitive impairment in congestive heart failure: a pilot case-control study.
Beer C; Ebenezer E; Fenner S; Lautenschlager NT; Arnolda L; Flicker L; Almeida OP
Intern Med J; 2009 Sep; 39(9):600-5. PubMed ID: 19220544
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Cognitive Function, Depression/Anxiety and Functional Parameters in Patients Admitted for Congestive Heart Failure.
Feola M; Garnero S; Vallauri P; Salvatico L; Vado A; Leto L; Testa M
Open Cardiovasc Med J; 2013; 7():54-60. PubMed ID: 24044027
[TBL] [Abstract][Full Text] [Related]
15. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
Pascual-Figal DA; Peñafiel P; Nicolas F; de la Morena G; Ansaldo P; Redondo B; Sánchez Mas J; Valdés M
Rev Esp Cardiol; 2008 Mar; 61(3):260-8. PubMed ID: 18361899
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
Scardovi AB; De Maria R; Coletta C; Aspromonte N; Perna S; Cacciatore G; Parolini M; Ricci R; Ceci V
J Card Fail; 2007 Aug; 13(6):445-51. PubMed ID: 17675058
[TBL] [Abstract][Full Text] [Related]
20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
